Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-30 5:08 pm Purchase | 2023-03-28 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 5,561,118 10.700% | 662,745![]() (+13.53%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 4,898,373 9.400% | 2,054,616![]() (+72.25%) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II, L.P. | 3,517,125 6.800% | 696,624![]() (+24.70%) | Filing History |
| 2023-02-10 4:35 pm Sale | 2022-12-31 | 13G | GH Research PLC GHRS | Schonharting Florian | 14,824,419 28.500% | -245,760![]() (-1.63%) | Filing History |
| 2023-02-10 4:33 pm Sale | 2022-12-31 | 13G | GH Research PLC GHRS | Terwey Theis H | 6,188,070 11.900% | -235,830![]() (-3.67%) | Filing History |
| 2023-02-09 10:59 am Sale | 2023-02-09 | 13G | GH Research PLC GHRS | FMR LLC | 4,455,981 8.565% | -746,513![]() (-14.35%) | Filing History |
| 2022-05-27 4:05 pm Purchase | 2022-05-17 | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II, L.P. | 2,820,501 5.400% | 2,820,501![]() (New Position) | Filing History |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | GH Research PLC GHRS | FMR LLC | 5,202,494 10.000% | 111,929![]() (+2.20%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 2,843,757 5.500% | -135,198![]() (-4.54%) | Filing History |
| 2022-02-14 12:53 pm Purchase | 2021-12-31 | 13G | GH Research PLC GHRS | BIOTECHNOLOGY VALUE FUND L P | 9,275,158 17.800% | 9,275,158![]() (New Position) | Filing History |
| 2022-02-09 4:45 pm Purchase | 2021-12-31 | 13G | GH Research PLC GHRS | Schonharting Florian | 15,070,179 29.000% | 15,070,179![]() (New Position) | Filing History |
| 2022-02-09 4:45 pm Purchase | 2021-12-31 | 13G | GH Research PLC GHRS | Terwey Theis H | 6,423,900 12.300% | 6,423,900![]() (New Position) | Filing History |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | GH Research PLC GHRS | FMR LLC | 5,090,565 9.785% | 5,090,565![]() (New Position) | Filing History |
| 2021-07-09 4:31 pm Purchase | 2021-06-29 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 2,978,955 5.900% | 2,978,955![]() (New Position) | Filing History |

